Abstract
Tumour necrosis factor-α (TNF-α) is a cytokine that can induce cell death of different cancers via a cellular cascade of proteases, the caspases. However, TNF-α has been detected in tumour and serum of patients with head and neck squamous cell carcinoma (HNSCC), and tumour cell lines derived from this environment often exhibit resistance to TNF-α-induced cell death. Cell death mediated by TNF-α and caspases may be inhibited by cytoprotective genes regulated by transcription factor nuclear factor-κB (NF-κB). We recently showed that NF-κB is constitutively activated in HNSCC, and that inhibition of NF-κB by expression of a nondegradable mutant inhibitor of NF-κB, IκBαM, markedly decreased survival and growth of HNSCC cells in vivo. In the present study, we examined the TNF-α sensitivity and response of HNSCC with constitutively active NF-κB, and of HNSCC cells in which NF-κB is inhibited by stable expression of a dominant negative mutant inhibitor, IκBαM. Human lines UM-SCC-9, 11B and 38, previously shown to exhibit constitutive activation of NF-κB, were found to be highly resistant to growth inhibition by up to 104U/ml of TNF-α in 5 day MTT assay. These TNF-α resistant HNSCC lines expressed TNF receptor I, and exhibited constitutive and TNF-α-inducible activation of NF-κB as demonstrated by nuclear localization of NF-κB p65 by immunohistochemistry. UM-SCC-9 I11 cells which stably expressed an inhibitor of NF-κB, IκBαm, were susceptible to TNF-α-induced growth inhibition. DNA cell cycle analysis revealed that TNF-α induced growth inhibition was associated with accumulation of cells with sub-G0/G1 DNA content. Cell death was demonstrated by trypan blue staining, and was blocked by caspase inhibitor. We conclude that HNSCC that exhibit constitutive and TNF-α-inducible activation of transcription factor NF-κB are resistant to TNF-α, and that inhibition of NF-κB sensitizes HNSCC to TNF-α caspase-mediated cytotoxicity. The demonstration of the role of activation of NF-κB in resistance of HNSCC to TNF-α may be helpful in the identification of potential targets for pharmacological, molecular and immune therapy of HNSCC. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dorken B (1997) Constitutive nuclear factor-κB-Re1A activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100: 2961–2969
Beg AA and Baltimore D (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274: 782–784
Bellas RE and Sonenshein GE (1999) Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function. Cell Growth Differ 10: 287–294
Briskin KB, Fady C, Wang M and Lichtenstein A (1996) Apoptotic inhibition of head and neck squamous cell carcinoma cells by tumor necrosis factor alpha. Arch Otolaryngol Head Neck Surg 122: 559–563
Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY and Ballard DW (1995) Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol 15: 2809–2818
Brown K, Gerstberger S, Carlson L, Franzoso G and Siebenlist U (1995) Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485–1488
Carswell EA and Old LJ (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666–3670
Chen Z, Colon I, Ortiz N, Callister M, Pegram M, Arosarena O, Strome S, Nicholson JC and Van Waes C (1998) Effects of IL-1α, IL-1RA and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res 58: 3668–3676
Coffman FD, Haviland DL, Green LM and Ware CF (1989) Cytotoxicity by tumor necrosis factor is linked with the cell cycle but does not require DNA synthesis. Growth Factors 1: 357–64
Dealtry GB and Naylor MS (1987) DNA fragmentation and cytotoxicity caused by tumor necrosis factor is enhanced by interferon-γ. Eur J Immunol 17: 689–693
Dong G, Chen Z, Kato T and Van Waes C (1999) The host environment promotes the constitutive activation of nuclear factor-κB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Research 59: 1–10
Duffey D, Chen Z, Dong G, Ondrey FG, Wolf JS, Brown K, Siebenlist U and Van Waes C (1999) Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 59: 3468–3474
Fraker DL, Alexander HR and Pass HI (1995) Biologic therapy with TNF: Systemic administration and isolation-perfusion. In: Biologic Therapy of Cancer, (2nd ed.) VT Vincent Jr, S Hellman, SA Rosenberg. pp 329–345, J.B. Lippincott Company: Philadelphia
Fransen L and Ruysschaert MR (1986) Recombinant tumor necrosis factor: Species specificity for a variety of human and murine transformed cell lines. Cell Immunol 100: 260–267
Gapany M, Dawson DE, Schriever C, Burgess R, Gipple, JR and Riggs CE Jr (1990) Tumor necrosis factor and cytotoxic agents. Effect on squamous carcinoma lines. Arch Otolaryngol Head Neck Surg 116: 436–9
Giardina C, Boulares H and Inan MS (1999) NSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. Biochim Biophys Acta 1448: 425–38
Haranaka K and Satomi N (1981) Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jpn J Exp Med 51: 191–194
Hu H and Lozano G (1994) NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269: 20067–20074
Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H and Baeuerle PA (1995) Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol Chem Hoppe Seyler 376: 9–16
Kaltschmidt G, Kaltschmidt C, Hehner SP, Droge W and Schmitz ML (1999) Repression of NF-kappaB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene 18: 3213–3225
Kirch HC, Flaswinkel S, Rumpf H, Brockmann D and Esche H (1999) Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max. Oncogene 18: 2728–2738
Klefstrom J, Arighi E, Littlewood T, Jaattela M, Saksela E, Evan GI and Alitalo K (1997) Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation. EMBO J 16: 7382–7392
Knerer B, Hulla W, Martineck H, Formanek M & Temmel A Kornfehl J (1996) IL-1 and TNF-alpha but no IL-2 expression is found in squamous cell carcinoma of the head and neck by RT-PCR. Acta Otolaryngol (Stockh) 116: 132–136
Kurokawa H, Yamashita M, Yamashita Y, Murata T, Miura K and Kajiyama M (1998) Estimation of tumor necrosis factor-alpha in the diagnosis, the prognosis and the treatment follow-up of oral squamous cell carcinoma. Fukuoka Igaku Zasshi 89: 312–320
La Rosa FA, Pierce JW and Sonenshein GE (1994) Differential regulation of the c-Myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol Cell Biol 14: 1039–1044
Larrick JW and Wright SC (1990) Cytotoxic mechanism of tumor necrosis factor-α. FASEB J 4: 3215–3223
Laster SM, Wood JG and Gooding LR (1998) Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 141: 2629–2634
Liu ZG, Hsu H, Goeddel DV and Karin M (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565–576
Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ and Baldwin AS Jr (1997) Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278: 1812–1815
Monchimatsu I, Tsukuda M, Furukawa S, Watanabe S, Kubota A and Yanoma S (1993) The sensitivity of head and neck squamous cell carcinomas to tumor necrosis factor-alpha. Biotherapy 6: 239–244
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr and Sledge GW Jr (1997) Constitutive activation of NF-κB during progression of breast cancer to hormone independent growth. Mol Cell Bio 17: 3629–3639
Neta R (1997) Modulation with cytokines of radiation injury: suggested mechanisms of action. Environ Health Perspect 105 Suppl.6: 1463–1465
Olieman AF, Lienard D, Eggermont AM, Kroon BB, Lejeune FJ, Hoekstra HJ and Koops HS (1999) Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg 134: 303–307
Ondrey F, Dong G, Sunwoo J, Chen Z, Wolf JS, Crowl-Bancroft CV, Mukaida N and Van Waes C (1999) Constitutive activation of transcription factors NF-κB, AP-1 and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express proinflammatory and proangiogenic cytokines. Mol. Carcinogenesis 26: 119–129
Otsuka G, Nagaya T, Saito K, Mizuno M, Yoshida J and Seo H (1999) Inhibition of Nuclear Factor-κB activation confers sensitivity to tumor necrosis factor-α by impairment of cell cycle progression in human glioma cells. Cancer Res 59: 4446–4452
Parks RR, Yan SD and Huang CC (1994) Tumor necrosis factor-alpha production in human head and neck squamous cell carcinoma. Laryngoscope 104: 860–4
Pocsik E, Mihalik R, Penzes M, Loetscher H, Gallati H and Aggarwal BB (1995) Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors. J Cell Biochem 59: 303–316
Sacchi M, Klapan I, Johnson JT and Whiteside TL (1991) Antiproliferative effects of cytokines on squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 117: 321–326
Schmid DS, Tite JP and Ruddle NH (1986) DNA fragmentation: Manifestation of target cell destruction mediated by cytotoxic T-cell lies, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. Proc Natl Acad Sci USA 83: 1881–1885
Schuger L, Dixit VM, Carey TE and Varani J (1990) Modulation of squamous carcinoma cell growth, morphology, adhesiveness and extracellular matrix production by interferon-gamma and tumor necrosis factor-alpha. Pathobiology 58: 279–286
Shattuck-Brandt RL and Richmond A (1997) Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res 57: 3032–3039
Shih SC and Stutman O (1996) Cell cycle-dependent tumor necrosis factor apoptosis. Cancer Res 56: 1591–1598
Soylu L, Ozcan C, Cetik F, Paydas S, Kiroglu M, Aydogan B, Sargin O, Ozsahinoglu C and Seyrek E (1994) Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck. Am J Otolaryngol 15: 281–285
Sugarman BJ and Aggarwal BB (1985) Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro. Science 230: 943–945
Sun L and Carpenter G (1998) Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium. Oncogene 16: 2095–2102
Tartaglia LA and Goeddel DV (1992) Two TNF receptors. Immunol Today 13: 151–153
Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S and Baeuerle PA (1995) Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J 14: 2876–2883
Urban JL and Schreiber H (1983) Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity. J Exp Med 157: 642–656
Urban JL, Shepard HM, Rothstein JL, Sugarman BJ and Schreiber H (1986) Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 83: 5233–5237
Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma I (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787–789
Van de Loosdrecht A, Ossenkoppele GJ, Beelen RH, Broekhoven MG and Langenhuijsen MM (1993) Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins. Cancer Res 53: 4399–407
Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamoto S (1995) Rel/NF-kB/IkB family: intimate tales of association and dissociation. Gene Dev 9: 2723–2735
Von Biberstein SE, Spiro JD, Lindquist R and Kreutzer DL (1995) Enhanced tumor cell expression of tumor necrosis factor receptors in head and neck squamous cell carcinoma. Am J Surg 170: 416–422
Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV and Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331–367
Wan JM, Fogt F, Bistrian BR and Istfan NW (1993) Evaluation of antitumor effect of tumor necrosis factor in terms of protein metabolism and cell cycle kinetics. Am J Physiol 265: 365–34
Wang C-Y, Mayo MW and Baldwin AS (1996) TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274: 784–787
Wang C-Y, Mayo MW, Korneluk RG, Goeddel DV and Baldwin AS (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (Wash) 281: 1680–1683
Watanabe N, Niitsu Y, Yamauchi N, Neda H, Sone H, Maeda M and Urushizaki I (1987) Cell cycle specificity of tumor necrosis factor and its receptor. Cell Biol Int Rep 11: 813–817
Wolf JS, Chen Z, Dong G, Sunwoo JB and Van Waes C (1999) Induction of cell proliferation and IL-8 expression by autocrine expression of IL-1α is associated with activation of NF-κB and AP-1 in head and neck squamous cell carcinoma. Proc Amer Assoc for Cancer Research 1177,
Wood LD and Richmond A (1995) Constitutive and cytokine induced expression of the melanoma growth stimulatory activity GRO alpha gene requires both NF-κB and novel constitutive factors. J Biol. Chem 270: 30619–30626
Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH and Sonenshein GE (1996) Inhibition of NF-kappa B/Rel induces apoptosis of murine B cells. EMBO J 15: 4682–4690
Wu MX, Ao Z, Prasad KVS, Wu R and Schlossman SF (1998) IEX-IL, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281: 998–1001
Younes F, Quartey EL, Kiguwa S and Partridge M (1996) Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma. Oral Dis 2: 25–31
Zong WX, Edelstein LC, Chen C, Bash J and Gelinas C (1999) The prosurvival BC1–2 homolog Bfl/A1 is a direct transcriptional target of NF-kappaB that blocks TNF alpha-induced apoptosis. Genes Dev 13: 382–387
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Duffey, D., Crowl-Bancroft, C., Chen, Z. et al. Inhibition of transcription factor nuclear factor-κB by a mutant inhibitor-κBα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death. Br J Cancer 83, 1367–1374 (2000). https://doi.org/10.1054/bjoc.2000.1423
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1423
Keywords
This article is cited by
-
Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas
Scientific Reports (2021)
-
Cell death in head and neck cancer pathogenesis and treatment
Cell Death & Disease (2021)
-
Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer
European Archives of Oto-Rhino-Laryngology (2015)
-
Head and Neck Squamous Cell Cancer: Biology (II) and Translational Methods
Indian Journal of Otolaryngology and Head & Neck Surgery (2007)
-
Granulocyte macrophage-colony stimulating factor and interleukin-3 increase expression of type II tumour necrosis factor receptor, increasing susceptibility to tumour necrosis factor-induced apoptosis. Control of leukaemia cell life/death switching
Cell Death & Differentiation (2004)